Digest AID

Advancing digestive healthcare through artificial intelligence

DigestAID is a Portuguese medical technology company developing artificial intelligence for digestive healthcare. Its Deep Capsule® software helps clinicians review small-bowel capsule endoscopy images, turning extensive imaging data into a more efficient clinical review process.
At the WellTech Innovation Village, DigestAID showcases how it translates AI research into regulated medical technology. Deep Capsule® received FDA 510(k) clearance in March 2026 as a Class II medical device, authorising its marketing in the United States for its specified intended use. The cleared indication is to help reduce image-review time in adult patients undergoing capsule endoscopy for suspected small-bowel bleeding.
The clinical validation submitted to the FDA included 330 capsule endoscopy examinations. AI-assisted physician review showed non-inferior diagnostic yield compared with conventional review, along with a significant reduction in mean reading time. The software supports, rather than replaces, clinical judgement: qualified medical professionals remain responsible for interpreting the findings.
DigestAID brings an international perspective on how AI can support specialist workflows, combining clinical validation, medical imaging and regulatory development to address practical challenges in digestive healthcare.
Showcase focus
Clinical AI · Digestive health · Capsule endoscopy · Medical image analysis · FDA-cleared technology.